The University of Minnesota has been awarded a five-year $8.2 million grant from the The National Cancer Institute (NCI) to develop a cell migration simulator that will predict how cancer cells move throughout the body.Read More
Science Market Update
Study Shows Chemopreventative Potential of Kava-Derived Compound
suggests a sandwich board on Tenth Street between First Avenue and Avenue A, in the East Village.Sometimes, the most simple and elegant solution to a problem has already been known for centuries. In 2014, University of Minnesota researchers explored the medicinal capacity of an ancient plant - Piper methysticum, c ommonly known as kava. However, concerns about kava being toxic to the liver have resulted in diminished use. Now, a recently published study has found that a specific kava derivative may have potential to combat cancer without causing any damage to liver cells.
More Research and Cancer articles:
Acute lymphoblastic leukemia (ALL) is the most common type of childhood cancer, affecting nearly 6 thousand children in the US annually. Recently, a possible relationship has been identified, which may provide valuable insight into why this cancer develops and how to prevent it.Read More
Until recently, nerve damage has been considered irreparable and impossible to treat. Only now are we seeing breakthroughs in nerve care such as Washington University’s study on preventing axon degeneration and UC Irvine’s study on regenerating nerves with salmon protein. Taking things one step farther, a University of Minnesota, Twin Cities research group has developed a method to foster nerve regrowth using 3D printing.Read More
Parkinson’s disease and other tremor-causing dysfunctions can be debilitating. Researchers at the University of Minnesota, Twin Cities have developed a treatment that in most cases completely restores motor activity to patients.Read More
As one of the leading research institutions in the Midwest, it is no surprise that the University of Minnesota, Twin Cities is expanding its research space. Construction crews have been hard at work on the newest research building on-campus, the Microbiology Research Facility, which is expected to be completed by the end of 2015, with an open and operating in January, 2016.Read More
The human immunodeficiency virus, known more commonly as HIV, is still at large today. With no known cure, the most researchers have been able to do is mitigate the effects of the virus. However, there are certain people who, despite being exposed to HIV, simply do not get infected. A team of biologists at the University of Minnesota, Twin Cities set out to find whether genetic differences play a role in this “immunity” to HIV.Read More
The University of Minnesota is partnering with Fairview Health Services to build a new $182.5 million outpatient care center. The new University of Minnesota facility is expected to be complete by early 2016 at the latest. One of the economic benefits of this new partnership is that University of Minnesota faculty physicians will also be able to share directly in the revenue of the center.
Tags: 2014, University of Minnesota, University of Minnesota St. Paul, Minnesota, University of Minnesota Twin Cities, BioResearch Product Faire Event, Research Funding, Minneapolis, MN, new facilities, new facility, St. Paul
When we jump into the swimming pool for some last-minute summer revelry, the worst part of getting out is the feeling of residual chlorine on our bodies. The environment doesn’t respond well to chlorine either- several synthetic chlorine-based compounds are toxic when released into nature and have taken part in the development of numerous superfund sites. Fortunately, a team from the University of Minnesota’s BioTechnology Institute is working on a way to clean up this chlorine, with help from some hungry bacteria.
Tags: 2014, Midwest, 2013, University of Minnesota, University of Minnesota St. Paul, Minnesota, University of Minnesota Twin Cities, Rochester, Mayo Clinic, University of Minneapolis, BioResearch Product Faire Event, Minneapolis, Front Line, St. Paul, St.Paul, UMinn, UMinnSP, RMN
Yesterday the police were on high alert, cracking down harder than ever on the sale, possession and use of illegal fireworks. But every day, several Americans light up something far more lethal. Cigarette smoking is the leading cause of preventable death in the United States, and remains so dangerous largely due the addictive properties of nicotine. In an effort to curb that dependency, researchers from the University of Minnesota are developing a vaccine that will grant immunity to nicotine.
Tags: 2014, Midwest, 2013, University of Minnesota, University of Minnesota St. Paul, Minnesota, University of Minnesota Twin Cities, BioResearch Product Faire Event, Minneapolis, MN, St. Paul, St.Paul, UMinn, UMinnSP, Twin Cities, U-M